1. Delayed inflammation decrease is associated with mortality in Tocilizumab-treated critically ill SARS-CoV-2 patients: A retrospective matched-cohort analysis. Issue 1 (January 2022) Authors: Urbina, Tomas; Lavillegrand, Jean-Rémi; Garnier, Marc; Mekinian, Arsene; Pacanowski, Jerome; Mario, Nathalie; Dumas, Guillaume; Hariri, Geoffroy; Pilon, Antoine; Darrivère, Lucie; Fartoukh, Muriel; Guidet, Bertrand; Maury, Eric; Leblanc, Judith; Chantran, Yannick; Fain, Olivier; Lacombe, Karine; ... Journal: Innate immunity Issue: Volume 28:Issue 1(2022) Page Start: 3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. MALDI‐TOF MS applied to apoC‐III glycoforms of patients with congenital disorders affecting O‐glycosylation. Comparison with two‐dimensional electrophoresis. Issue 7 (24th March 2015) Authors: Yen‐Nicolaÿ, Stéphanie; Boursier, Céline; Rio, Marlène; Lefeber, Dirk J.; Pilon, Antoine; Seta, Nathalie; Bruneel, Arnaud; Cutler, Paul; Voshol, Hans Journal: Proteomics Issue: Volume 9:Issue 7/8(2015) Page Start: 787 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗